Pmv Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 6.92
| PMVP Stock | USD 1.60 0.01 0.63% |
Pmv |
Pmv Pharmaceuticals Target Price Odds to finish over 6.92
The tendency of Pmv Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 6.92 or more in 90 days |
| 1.60 | 90 days | 6.92 | close to zero percent |
Based on a normal probability distribution, the odds of Pmv Pharmaceuticals to move over $ 6.92 or more in 90 days from now is close to zero percent (This Pmv Pharmaceuticals probability density function shows the probability of Pmv Stock to fall within a particular range of prices over 90 days) . Probability of Pmv Pharmaceuticals price to stay between its current price of $ 1.60 and $ 6.92 at the end of the 90-day period is about 34.38 .
Given the investment horizon of 90 days Pmv Pharmaceuticals has a beta of 0.55 indicating as returns on the market go up, Pmv Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Pmv Pharmaceuticals will be expected to be much smaller as well. Additionally Pmv Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Pmv Pharmaceuticals Price Density |
| Price |
Predictive Modules for Pmv Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pmv Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pmv Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pmv Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pmv Pharmaceuticals is not an exception. The market had few large corrections towards the Pmv Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pmv Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pmv Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.03 | |
β | Beta against Dow Jones | 0.55 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | -0.03 |
Pmv Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pmv Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pmv Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pmv Pharmaceuticals may become a speculative penny stock | |
| Pmv Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (68.96 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pmv Pharmaceuticals currently holds about 277.43 M in cash with (55.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Pmv Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: PMV Pharmaceuticals files 200M mixed securities shelf - TipRanks |
Pmv Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pmv Stock often depends not only on the future outlook of the current and potential Pmv Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pmv Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48 M | |
| Cash And Short Term Investments | 203.1 M |
Pmv Pharmaceuticals Technical Analysis
Pmv Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Pmv Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pmv Pharmaceuticals. In general, you should focus on analyzing Pmv Stock price patterns and their correlations with different microeconomic environments and drivers.
Pmv Pharmaceuticals Predictive Forecast Models
Pmv Pharmaceuticals' time-series forecasting models is one of many Pmv Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pmv Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Pmv Pharmaceuticals
Checking the ongoing alerts about Pmv Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pmv Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Pmv Pharmaceuticals may become a speculative penny stock | |
| Pmv Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (68.96 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pmv Pharmaceuticals currently holds about 277.43 M in cash with (55.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Pmv Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: PMV Pharmaceuticals files 200M mixed securities shelf - TipRanks |
Additional Tools for Pmv Stock Analysis
When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.